Showing 15 posts of 244 posts found.


MSD chalks up two HIV drug approvals in Europe

November 30, 2018
Medical Communications, Sales and Marketing Delstrigo, EU, Europe, HIV, MSD, Pifeltro, pharma

MSD has announced the European approval of two of its products for the treatment of HIV: the single-tablet combination Delstrigo …


Mundipharma’s Neulasta biosimilar approved in EU

November 26, 2018
Sales and Marketing Amgen, EU, Europe, Mundipharma, Neulasta, Pelmeg, pharma

Mundipharma has revealed that Pelmeg, its biosimilar version of Amgen’s Neulasta (pegfilgrastim), has been awarded marketing approval by the European …


Novartis’ gene therapy Luxturna becomes first approved European therapy for vision loss subtype

November 23, 2018
Medical Communications, Sales and Marketing EU, Europe, Luxturna, Novartis, pharma, vision loss

Novartis has revealed that its one-time gene therapy Luxturna (voretigene neparvovec) has been awarded approval by the European Commission to …


Eli Lilly’s Emgality cleared for treatment of migraine in Europe

November 20, 2018
Manufacturing and Production, Sales and Marketing EU, Eli Lilly, Emgality, Europe, migraine, pharma

Eli Lilly’s Emgality (galcanezumab) has secured approval from the European Commission for the prophylaxis of migraine in adult patients who …


EU rules may be stifling Britain’s biotech industry

November 19, 2018
Sales and Marketing EU, biotech, britain, funding, grants, industry

EU rules are stifling Britain’s biotech industry, according to companies who talked to British newspaper The Daily Telegraph. The newspaper …


Top Ten most popular articles on this week

October 5, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, Jannsen, NHS, Novartis, Novo Nordisk, dementia, top 10

As September came to a close and October began the UK was hit hard in the headlines after American firm …


MHRA to consult on potential for no-deal Brexit

October 5, 2018
Medical Communications EU, MHRA, brexit, uk politics

The Medicines and Healthcare products Regulatory Agency (MHRA) has opened a consultation on how its legislation and regulatory processes would …

European countries unprepared for Alzheimer’s innovations, study shows

October 1, 2018
Sales and Marketing Alzheimer's dementia, Alzheimer’s & dementia, EU, Euroepan Union, RAND corporation, research

European healthcare systems are not prepared for new developments in preventative therapies for Alzheimer’s disease, according to research conducted by …


EMA says pharma industry now more prepared for Brexit

September 27, 2018
Manufacturing and Production, Medical Communications EMA, EU, brexit, products, qppv

In July of this year the European Medicines Agency (EMA) identified significant gaps in the pharmaceutical industry’s preparedness for Brexit. …


EU approval for Mylan and Fujifilm’s Humira biosimilar

September 21, 2018
Medical Communications, Sales and Marketing EU, Europe, Humira, Mylan, biosimilar, pharma

The European Commission has approved its fifth biosimilar of the world’s best-selling drug, Abbvie’s Humira (adalimumab), granting marketing authorisation to …

Novo Nordisk stockpiles 16 weeks’ worth of insulin in preparation for hard Brexit

September 10, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, Novo Nordisk, UK, brexit, insulin, pharma, stockpiles

Danish multinational Novo Nordisk has announced that they are increasing their stocks of insulin products to ensure that there are …


Drug safety: UK and EU post-Brexit

September 10, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, Europe, MHRA, UK, brexit, drug safety, pharmacovigilance

What does Brexit mean for drug safety in Europe and the United Kingdom? Louis Goss looks into Britain’s exit from …


Keytruda scores ground-breaking European approval in lung cancer subgroup

September 10, 2018
Sales and Marketing Cancer, EU, Europe, MSD, Merck, NSCLC, keytruda, lung cancer, pharma

Keytruda (pembrolizumab) has chalked up yet another approval for MSD, this time in Europe in combination with permextred and platinum-based …

Puma Biotech’s breast cancer drug authorised by European Commission, despite prior concerns

September 5, 2018
Research and Development Cancer, EU, breast cancer, ec approval, puma biotechnology

Puma Biotechnology have received European Commission marketing authorisation for Nerlynx (neratinib) despite prior concerns as to the safety and efficacy …

Latest content